| | Title | Author(s) | Year | View Count | | 1 |  | M2 macrophages promotes tumor growth and invasion in hepatocellular carcinoma | Yeung, WH; Lee, KW; Geng, W; Li, C; Ng, KTP; Lo, CM; Guan, X; Poon, RTP; Fan, ST; Man, K | 2012 | 78 |
| 2 |  | The potential role of CD44 in liver regeneration | Lam, CT; Yang, Z; Ng, MNP; Wan, TMH; Lau, JCS; Ho, DWY; Fan, ST; Poon, RTP | 2012 | 84 |
| 3 | | Trans-arterial chemo-embolization (TACE) is safe and efficient for elderly patients with advanced hepatocellular carcinoma (HCC): Results from an international meta-database | Cohen, MJ; Levy, I; Barak, O; Bloom, AI; Fernández Ruiz, M; Di Maio, M; Perrone, F; Poon, RTP; Shouval, D; Yau, TCC; Shibolet, O | 2012 | 88 |
| 4 | | Assessment of the 7th AJCC staging system in prognostic stratification of resected hepatocellular carcinoma | Lo, CLR; Ng, IOL; Poon, RTP | 2012 | 67 |
| 5 | | A Phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2 and VEGFR in advanced hepatocellular carcinoma (HCC) | Yau, T; Yen, CJ; Chen, PJ; Chau, Y; Lencioni, R; Kallender, H; Ottesen, LH; Poon, RTP | 2011 | 231 |
| 6 | | Evaluation of the new 7th AJCC/UICC staging system for resectable hepatocellular carcinoma (Abstract) | Chan, ACY; Fan, ST; Poon, RTP; Lo, CM | 2011 | 166 |
| 7 | | The outcomes of elderly patients with advanced hepatocellular carcinoma treated with single agent Sorafenib (Abstract) | Chan, P; Wong, H; Yao, TJ; Tang, VWK; Wong, H; Fan, ST; Poon, RTP; Yau, TCC | 2011 | 117 |
| 8 | | Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract) | Yau, TCC; Chan, P; Cheung, FY; Lee, AS; Yau, TK; Choo, SP; Toh, HC; Leung, AK; Wong, JS; Wong, S; Lau, J; Pang, RWC; Fan, ST; Poon, RTP | 2011 | 224 |
| 9 | | Impact of antiviral therapy on the survival outcome of patients after major hepatectomy for hepatitis B-related hepatocellular carcinoma | Chan, ACY; Chok, K; Yuen, WK; Poon, R; Lo, CM; Fan, ST | 2011 | 196 |
| 10 | | Salvage living donor liver transplantation for recurrent hepatocellular carcinoma: salvaging the unsalvageable? | Chan, ACY; Chok, KSH; Cheung, TT; Sharr, WW; Tsang, SHY; Chan, SC; Poon, RTP; Lo, CM; Fan, ST | 2011 | 140 |
| 11 | | Tolerance of high intensity focused ultrasound ablation in patients of hepatocellular carcinoma | Cheung, TT; Poon, RTP; Lo, CM; Fan, ST | 2011 | 236 |
| 12 | | Rapid assessment of ICG by pulse desitometry: a validatory study of 70 patients | Cheung, TT; Poon, RTP; Lo, CM; Fan, ST | 2011 | 132 |
| 13 | | High intensity focused ultrasound as a bridging therapy for HCC patients on liver transplant waiting list. Hype or hope? (Plenary Session) | Cheung, TT; Chan, SC; Poon, RTP; Fan, ST; Lo, CM | 2011 | 164 |
| 14 | | Characterization of the epigenetic modification patterns of pluripotent stem cell genes in human cancers | Wang, X; Ng, RK; Ming, X; Zhang, W; Lin, C; Poon, RTP; Fan, ST | 2011 | 156 |
| 15 | | A new prognostic classification scheme with treatment guidelines for Asian patients with hepatocellular carcinoma (HCC): the Hong Kong Combined Liver Cancer (HKCLC) classification | Tang, YF; Yao, T; Yau, CC; Fan, ST; Poon, RTP | 2011 | 151 |
| 16 | | Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II study | Yau, T; Leung, RC; Wong, H; Chiu, J; Chan, P; Pang, R; Fan, ST; Poon, RTP | 2011 | 164 |
| 17 | | The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosis | Chiu, J; Tang, YF; Yao, TJ; Wong, A; Wong, H; Leung, R; Chan, P; Cheung, TT; Poon, RTP; Fan, ST; Yau, CC | 2011 | 192 |
| 18 | | Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) | Finn, RS; Poon, RTP; Yau, T; Klumpen, H; Chen, L; Kang, Y; Kim, T; Gomez-Martin, C; Rodriguez-Lope, C; Kunz, T; Paquet, T; Asubonteng, K; Winkler, RE; Anak, O; Sellami, DB; Bruix, J | 2011 | 163 |
| 19 | | Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocellular carcinoma after sorafenib failure: a prospective, open-label, phase II study (Abstract) | Yau, TCC; Leung, RCY; Wong, H; Chiu, J; Chan, P; Pang, RWC; Fan, ST; Poon, RTP | 2011 | 186 |
| 20 | | Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a novel target for liver cancer therapy (Poster & Abstract) | Lu, WJ; Lee, NPY; Kaul, SC; Poon, RTP; Wadhwa, R; Luk, JMC | 2011 | 123 |
|
